No impact of first-line systemic therapy on quality of life of patients with metastatic breast cancer? Data from the MaLife-project. 6. Juni 2014 Marschner, N., Tesch, H., Karcher, A., Ammon, A., Nusch, A., Boller, E., Spring, L., Jänicke, M., 2014. Oncol Res Treat 37 (suppl 5)(V371), 111. doi:10.1159/000368945 Abstract Treatment of chemotherapy-induced neutropenia with Lipegfilgrastim (Lonquex®): First interim analysis of the non-interventional study NADIR. Kurbacher, C., Diel, I., Egert, M., Fietz, T., Hurtz, H., Lück, A., Weide, R., Wolff, T., Zaiss, M., Teichmann, B., Harde, J., Scheuerlein, R., 2014. Weiterlesen Patients with brain metastases from advanced or metastatic renal cell carcinoma – Data from the clinical RCC Registry. Müller, L., Goebell, P., Reichert, D., Krieger, J., Jänicke, M., Harde, J., Koska, M., Marschner, N., 2014. Oncol Res Treat 37 (suppl.5)(P287), 91. doi:10.1159/000368945… Weiterlesen